Renal Cancer - Results from #5980

Clinicopathologic Analysis of PD-L1 and PD-L2 Expression in Renal Cell Carcinoma: Association with Oncogenic Proteins Status October 21, 2015

[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule] October 21, 2015

Extent of Renal Vein Invasion Influences Prognosis in Patients with Renal Cell Carcinoma October 21, 2015

[Prognostic factors for metastatic renal cell carcinoma treated with second-line targeted therapies] October 21, 2015

Management of Small Renal Masses in the Older Adult October 19, 2015

Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway. October 19, 2015

Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective study. October 19, 2015

[Bevacizumab as first-line therapy in metastatic renal cell carcinoma : Progression-free survival for 3 years] October 19, 2015

Safety and efficacy of sunitinib for advanced non-clear cell renal cell carcinoma October 19, 2015

PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis October 19, 2015

Comparison between the effects of one-day treatment regimen with cisplatin on renal function and various biochemical parameters in patients with gastric and lung cancer compared with two-days divided cisplatin treatment regimen October 19, 2015

Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomes October 8, 2015

Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes October 7, 2015

Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. October 7, 2015

Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase October 6, 2015

Impact of reduced GFR and proteinuria on overall survival of renal cancer patients October 6, 2015

Long-Term Risk of Cancer in Survivors of Pediatric ESRD October 6, 2015

PD-1 inhibitor Nivolumab prolongs survival in advanced renal cell carcinoma - Commentary October 1, 2015

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma October 1, 2015

Detection of 18F-FDG PET/CT Occult Lesions with 18F-DCFPyL PET/CT in a Patient with Metastatic Renal Cell Carcinoma September 29, 2015

Page 300 of 456